Skip to main content
Sipai Health Technology Co., Ltd. logo

Sipai Health Technology Co., Ltd. — Investor Relations & Filings

Ticker · 314 LEI · 254900L2R8E2GUU04931 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 276 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 314

About Sipai Health Technology Co., Ltd.

http://www.medbankshealthtech.com

Sipai Health Technology Co., Ltd. (Medbanks) is a leading medical technology and health management company in China, driving the digital transformation of healthcare. The company connects patients, providers, pharmaceutical companies, and commercial insurers through its data-enabled platform, delivering accessible medical services. Sipai operates three core business lines. The Specialty Pharmacy Business runs the largest privately owned specialty pharmacy network in China, offering drug supply, pharmacy care, and full-cycle disease management for specialty drugs. The Physician Research Assistance segment includes the largest oncology site management organization (SMO) for clinical trials and provides independent medical imaging assessment services for Phase I-IV clinical trials via Xiaoying Technology. The Health Insurance Services segment offers customized insurance brokerage, health management, and comprehensive benefits solutions to insurance companies, corporate clients, and millions of individuals.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return - Changes in issued shares and share buybacks
Regulatory Filings
2026-05-05 English
Next Day Disclosure Return - Changes in issued shares and share buybacks
Regulatory Filings
2026-05-04 English
Next Day Disclosure Return - share buybacks
Regulatory Filings
2026-04-30 English
Next Day Disclosure Return - share buybacks
Regulatory Filings
2026-04-29 English
Next Day Disclosure Return - share buybacks
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) under the HKEX Listing Rules detailing changes in issued shares and treasury shares, specifically share repurchases (on‐market buybacks) and related confirmations. It provides detailed transaction data (dates, number of shares repurchased, prices, opening/closing balances) and is filed pursuant to Listing Rules 13.25A/10.06 and GEM rules. This is neither an annual/interim report nor an announcement of an upcoming report, but a disclosure of the company’s own share transactions. Therefore it falls under “Transaction in Own Shares” (POS).
2026-04-28 English
Next Day Disclosure Return - Changes in issued shares and share buybacks
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (Form FF305) under HKEX rules, detailing changes in issued shares and treasury shares (share repurchases and share awards/exercise of options). It provides specific transactional data on the company buying back shares and issuing/transferring treasury shares. This matches our category for company share repurchases/transactions in its own shares (POS).
2026-04-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.